Investigational
novartisnovartisnovartis
novartisnovartisnovartis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The dilemma of lacking data is<br />
a majorhindranceforusing<br />
NOEL‘s and uncertainty factors!<br />
NOVARTIS<br />
In vitro + in vivo genotoxicity assays are hazard identification<br />
tests, and thus do not provide data suitable for use in<br />
quantitative risk assessment<br />
Approach proposed (use of NOEL + UF) is unlikely to be<br />
feasible in most circumstances (no adequate data)!<br />
Pragmatic approach is needed (amount of impurity in µg/day<br />
considered as generally acceptable intake level)<br />
‣ The NOEL / UF approach can be used for toxicologically well<br />
characterized compounds, a condition, which is normally not<br />
met for impurities<br />
L. Müller, Swissmedic, 21-Oct-2003